CME · 10-Q · 2026Q3 · Full report

Capital Return Program

CME GROUP INC. · 2026-10-23 · Importance 26 · Surprise 24

CME Group maintained authorization to repurchase up to $3.0 billion of its outstanding Class A common stock through open-market, block, privately negotiated, or other transactions. At September 30, 2026, the maximum remaining repurchase authorization was $1.0 billion. Cash used in financing activities increased in the first nine months of 2026 partly because share repurchases increased; the filing does not state the dollar amount repurchased in this period.

Key facts

• CME Group's share repurchase program authorizes repurchases of up to $3.0 billion of its outstanding Class A common stock and has no expiration date. source
• The maximum remaining value of shares available for repurchase under CME Group's program was $1.0 billion at September 30, 2026. source
• CME Group's share repurchase program does not require it to buy a particular amount of stock and may be modified, suspended or terminated at any time. source